Viridian Therapeutics Inc. Insider Trading

VRDN

Last 12 months

Insiders sold 419K and bought nothing on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. Chief Legal Officer Jennifer Tousignant sold 348K on Aug 19, 100% of their stake, outside a plan. The last open-market buy by an executive or director was in Sep 2024.

Net open-market

−419K

0 buys · 2 sales

Under a 10b5-1 plan

of the value sold

Insiders who bought / sold

0 / 1

executives and directors

Last open-market buy

Sep 2024

Sep 27, 2024

Get an email when VRDN's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Aug 19	Jennifer Tousignant Chief Legal Officer	SoldNo plan 2 parts	14,212	$24.50 average	348K	100%	Form 4
May 11	Fairmount Healthcare Fund II L.p. Large holder	Bought	1,176,470	$17.00	$20M	30%	Form 4
Dec 31, 2025	Jennifer Tousignant Chief Legal Officer	SoldNo plan	2,272	$31.16	71K	100%	Form 4
Oct 23, 2025	Fairmount Healthcare Fund II GP LLC Large holder	Bought	454,545	$22.00	$10M	13%	Form 4

Aug 19No plan
Jennifer Tousignant
Chief Legal Officer · sold 14,212 at avg $24.50
348K
100% of stake
May 11
Fairmount Healthcare Fund II L.p.
Large holder · bought 1,176,470 at $17.00
$20M
30% of stake
Dec 31, 2025No plan
Jennifer Tousignant
Chief Legal Officer · sold 2,272 at $31.16
71K
100% of stake
Oct 23, 2025
Fairmount Healthcare Fund II GP LLC
Large holder · bought 454,545 at $22.00
$10M
13% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch VRDN, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with VRDN

CompareIntrinsic value

LXRXLexicon Pharmaceuticals, Inc.

$1.48+1.37%40

RMTIRockwell Medical, Inc.

$8.05-0.49%37

FBIOFortress Biotech Inc.

$1.97+1.55%59

PTGXProtagonist Therapeutics Inc.

$143.37+2.23%54

DERMJourney Medical Corp

$4.73+1.94%25

ASMBAssembly Biosciences Inc.

$19.87-0.25%19

ENTAEnanta Pharmaceuticals Inc.

$10.65+2.70%25

KURAKura Oncology Inc.

$7.61-22.98%10

Held by ETFs

VRDN is in 46 US ETFs. The largest of them, with VRDN's weight in each:

Spot a number that looks wrong? Check it in VRDN's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing VRDN

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.